[Treatment of cholecystopathies by Fumaria nebulisate].
In 85 patients with cholecystopathies the therapeutic effect of the Fumaria-preparation Oddibil was tested. The therapy was successful alltogether in 70%, in dyskinesias of biliary tract in more than 80%. The optimal therapeutic result was obtained after 10 days on an average. The difference between the Fumaria nebulisate and a placebo with regard to the efficacy was statistically significant. The amphocholeretic effect of the praparation is especially to be emphasized. Side-effects didn't occur.
D000328:Adult; D001657:Biliary Dyskinesia / Q000188:drug therapy; D001660:Biliary Tract Diseases / Q000188:drug therapy*; D002761:Cholangitis / Q000188:drug therapy; D002763:Cholecystectomy / Q000009:adverse effects; D002764:Cholecystitis / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D010936:Plant Extracts / Q000627:therapeutic use*
D010919:Placebos; D010936:Plant Extracts
Fumaria-Nebulisat in der Behandlung von Gallenwegerkrankungen.